The Patent Finder

Fountain Biopharma Inc.

Also on record
Records under this name other than patents Fountain Biopharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Fountain Biopharma Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,758,580Uses of antibodies to interleukin-6 in cancer treatment
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,370,443Method of treating autoimmune disease by administering antibodies to interleukin-6
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,234,035Antibodies to interleukin-6
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,540,673Methods for producing recombinant glycoproteins with modified glycosylation
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,745,729Methods for producing recombinant glycoproteins with modified glycosylation
Formerly held
In force
 · USPTO record
In forceUSPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited